New injection prompts fat cell self-destruction

Scientists have developed a new treatment called "CBL-514" aimed at effectively and safely reducing fat by autonomously destroying fat cells through a programmed cell death mechanism. Clinical trials have shown that this therapy can decrease subcutaneous and visceral fat by up to 12.01% over 12 weeks, with potential health benefits such as improved blood pressure and cholesterol levels. Further studies are currently needed to confirm the long-term safety of the treatment and its overall effects on the body.